Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients
详细信息 查看全文
- 作者：Jakub Tomasika ; b ; jt455@cam.ac.uk" class="auth_mail" title="E-mail the corresponding author ; Emanuel Schwarza ; emanuel.schwarz@zi-mannheim.de" class="auth_mail" title="E-mail the corresponding author ; Santiago G. Lagoa ; sl588@cam.ac.uk" class="auth_mail" title="E-mail the corresponding author ; Matthias Rothermundtc ; Matthias.Rothermundt@evkln.de" class="auth_mail" title="E-mail the corresponding author ; F. Markus Leweked ; e ; markus.leweke@zi-mannheim.de" class="auth_mail" title="E-mail the corresponding author ; Nico J.M. van Beverenb ; f ; g ; Nico.van.Beveren@deltapsy.nl" class="auth_mail" title="E-mail the corresponding author ; Paul C. Guesta ; paulcguest@yahoo.com" class="auth_mail" title="E-mail the corresponding author ; Hassan Rahmounea ; hr288@cam.ac.uk" class="auth_mail" title="E-mail the corresponding author ; Johann Steinerh ; steiner.johann@web.de" class="auth_mail" title="E-mail the corresponding author ; Sabine Bahna ; b ; sb209@cam.ac.uk" class="auth_mail" title="E-mail the corresponding author
- 关键词：Schizophrenia ; Olanzapine ; Biomarker ; Personalised medicine ; FABP3 ; CD36
- 刊名：Brain, Behavior, and Immunity
- 出版年：2016
- 出版时间：February 2016
- 年：2016
- 卷：52
- 期：Complete
- 页码：178-186
- 全文大小：849 K
文摘
- •
Pre-treatment H-FABP and CD36 predict response to olanzapine in schizophrenia.
- •
IL-10 levels may be associated with response to quetiapine.
- •
ACE and prolactin are increased by different antipsychotic treatments.
- •
Serum proteins may serve as markers of efficacy and side effects of antipsychotic medication.